ArticleTherapeutic advances in neurological disorders2018

Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature.

Jennifer Jeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.